Exclusive Summary

• Off-patent globally, establishing a mature generic market with ample entry opportunities.
• Tadalafil 5mg is a first-line treatment for ED and BPH, addressing a massive and continuously growing global patient pool with stable demand.
• Offers high patient compliance with convenient oral administration for daily therapy, significantly easing patient's medication burden.
• Provides significant cost advantages over originator drugs, aligning with global healthcare cost-reduction trends and facilitating market access and broader coverage.